Split History
ACST split history picture
Acasti Pharma (ACST) has 4 splits in our ACST split history database. The first split for ACST took place on December 12, 2003. This was a 1 for 89 reverse split, meaning for each 89 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 11.2359550561798 share position following the split. ACST's second split took place on October 15, 2015. This was a 1 for 10 reverse split, meaning for each 10 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 11.2359550561798 share position pre-split, became a 1.12359550561798 share position following the split. ACST's third split took place on August 31, 2021. This was a 1 for 8 reverse split, meaning for each 8 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 1.12359550561798 share position pre-split, became a 0.140449438202247 share position following the split. ACST's 4th split took place on July 10, 2023. This was a 1 for 6 reverse split, meaning for each 6 shares of ACST owned pre-split, the shareholder now owned 1 share. For example, a 0.140449438202247 share position pre-split, became a 0.0234082397003745 share position following the split.

When a company such as Acasti Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ACST split history from start to finish, an original position size of 1000 shares would have turned into 0.0234082397003745 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acasti Pharma shares, starting with a $10,000 purchase of ACST, presented on a split-history-adjusted basis factoring in the complete ACST split history. ACST split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/17/2014
End date: 04/15/2024
Start price/share: $504.00
End price/share: $3.36
Dividends collected/share: $0.00
Total return: -99.33%
Average Annual Total Return: -39.40%
Starting investment: $10,000.00
Ending investment: $66.70
Years: 10.00
Acasti Pharma is a biopharmaceutical company that is focused on developing and commercializing products for rare and orphan diseases by using its drug delivery technologies. Co.'s primary drug candidate, GTX-104, is an IV formulation of nimodipine designed to treat subarachnoid hemorrhage, a rare brain disorder. Co.'s other drug candidates are: GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia, an orphan pediatric genetic neurodegenerative disorder in young children; and GTX-101, which is a topical bioadhesive film-forming bupivacaine spray for Postherpetic Neuralgia, which causes debilitating pain following infection by the shingles virus. According to our ACST split history records, Acasti Pharma has had 4 splits.
Date Ratio
12/12/20031 for 89
10/15/20151 for 10
08/31/20211 for 8
07/10/20231 for 6
ACST is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ACUR Split History
ADK Split History
ADMP Split History
ADMS Split History
ADPT Split History
ADRO Split History
ADVM Split History
ADXS Split History
AEMD Split History
AEZS Split History

Also explore: ACST shares outstanding history

Email EnvelopeFree ACST Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
NFT Ltd. (MI)
WiSA Technologies, Inc. (WISA)
C3IS INC. (CISS)
Fluent, Inc. (FLNT)
TRACON Pharmaceuticals (TCON)
Agenus Inc. (AGEN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ACST Insider Buying

ACST Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.